BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3258959)

  • 1. Evaluation of the diagnostic value of the PABA test in the assessment of chronic pancreatic disease.
    Hoek FJ; Tytgat GN
    Neth J Med; 1988 Apr; 32(3-4):118-29. PubMed ID: 3258959
    [No Abstract]   [Full Text] [Related]  

  • 2. The PFD test for pancreatic disease patients.
    Miwa M; Kikuchi K; Senoue I; Watanabe H; Nomiyama T; Suzuki S; Harasawa S; Tani N; Miwa T; Sugita T
    Tokai J Exp Clin Med; 1981 Jul; 6(3):309-13. PubMed ID: 6975509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional examination of the pancreas with indirect methods (the NBT-PABA test and pancreolauryl test) in patients with chronic pancreatic diseases].
    Martínez Martínez LM; González Villarón L; Sánchez Sánchez R; Rodrigo Sáez L; de Castro del Pozo S
    Rev Clin Esp; 1985 Oct; 177(6):258-62. PubMed ID: 3878546
    [No Abstract]   [Full Text] [Related]  

  • 4. [The exocrine pancreatic function (PABA) test and its clinical applications].
    Zhou ZC; Zhang XQ; Chen MZ; Lu XH; Lu GJ; Bi ZH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Dec; 4(6):352-7. PubMed ID: 6221814
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of exocrine pancreatic function by the PABA test in patients with acute pancreatitis].
    Arenas M; Pérez-Mateo M; Graells ML; Sillero C; Vázquez N
    Rev Esp Enferm Apar Dig; 1986 Jul; 70(1):43-8. PubMed ID: 3488572
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pancreatic Function Diagnostant (PFD): a pancreatic exocrine function test with synthetic peptide, BT-PABA].
    Kubo Y; Kuwahara S; Tanikawa K
    Nihon Rinsho; 1980; 38(1):45-50. PubMed ID: 6993727
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnostic value of the NBT-PABA test in the functional evaluation of the exocrine pancreas].
    Kostić N; Bozanić M; Vuković A
    Srp Arh Celok Lek; 1992; 120(9-10):269-72. PubMed ID: 1306017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The peptide-PABA test. Methodological and clinical studies with a new indirect pancreatic function test].
    Bornschein W
    Fortschr Med; 1977 Nov; 95(42):2559-64. PubMed ID: 303211
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oral administration of a chymotrypsin-labile synthetic peptide, a new test for exocrine pancreatic function, and its diagnostic value in pancreatic diseases (author's transl)].
    Takayama T; Hayakawa T; Noda A; Aoki I; Horiguchi Y; Yamazaki Y; Ito K; Naruse S; Kondo T; Iinuma Y
    Nihon Naika Gakkai Zasshi; 1980 Apr; 69(4):447-53. PubMed ID: 6967099
    [No Abstract]   [Full Text] [Related]  

  • 10. Bentiromide--a test of pancreatic insufficiency.
    Med Lett Drugs Ther; 1984 May; 26(661):50. PubMed ID: 6609300
    [No Abstract]   [Full Text] [Related]  

  • 11. [The oral administration of N-benzoyl-L-tyrosyl-paraaminobenzoic acid (PFT) in the assessment of exocrine pancreatic function and its value within the diagnostic approach to pancreatic disease (author's transl)].
    Fettes F; Gyr K; Singeisen M; Kayasseh L; Stalder GA
    Z Gastroenterol; 1978 Mar; 16(3):141-8. PubMed ID: 305693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of the oral NBT-PABA test for the diagnosis of chronic pancreatitis].
    Meyer B; Gyr K
    Leber Magen Darm; 1987 Oct; 17(5):334-8. PubMed ID: 3500382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of test meals on the PED test.
    Miwa M; Kikuchi K; Senoue I; Watanabe H; Nomiyama T; Suzuki S; Harasawa S; Tani N; Miwa T
    Tokai J Exp Clin Med; 1981 Jan; 6(1):97-101. PubMed ID: 6973222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical study of exocrine pancreatic function test by oral administration by N-benzoyl-L-tyrosyl-p-aminobenzoic acid.
    Kimura T; Wakasugi H; Ibayashi H
    Digestion; 1981; 21(3):133-9. PubMed ID: 7011889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The study of exocrine pancreas function by means of orally administered N-benzoyl-L-tyrosyl-praaminobenzoic acid (BT-PABA-test). Evaluation after 5 years clinical experience].
    Lang C; Gyr K; Borer P; Kayasseh L; Stalder GA
    Schweiz Med Wochenschr; 1980 Apr; 110(14):522-8. PubMed ID: 6966425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PABA test for evaluation of exocrine pancreatic function: a review of the literature.
    Hoek FJ
    Neth J Med; 1988 Apr; 32(3-4):143-56. PubMed ID: 3283581
    [No Abstract]   [Full Text] [Related]  

  • 17. [The PABA test].
    Müller G; Biering A; Graubaum K; Jeschkeit H; Neubert K; Kleine R; Klapperstück M
    Dtsch Z Verdau Stoffwechselkr; 1984; 44(5):219-31. PubMed ID: 6334604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of p-aminobenzoic acid and its metabolites in urine and plasma by ion pair HPLC in the NBT-PABA pancreatic function test.
    Hung CT; Perrier DG; Schicker AM; Zoest AR
    Biomed Chromatogr; 1987 Feb; 2(1):13-6. PubMed ID: 3509869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of the peroral test with the chymotrypsin substrate 4-(N-acetyl-L-tyrosyl)aminobenzoic acid in patients with kidney diseases].
    Suranová M; Malis F; Horácková M; Vrzánová M; Zelenková J; Osten J
    Vnitr Lek; 1983 Sep; 29(9):890-4. PubMed ID: 6605613
    [No Abstract]   [Full Text] [Related]  

  • 20. B.T.PABA test: a new absorption test.
    Miwa M; Senoue I; Watanabe H; Nomiyama T; Sakita R; Suzuki S; Harasawa S; Tani N; Miwa T
    Tokai J Exp Clin Med; 1980 Jan; 5(1):1-13. PubMed ID: 6966841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.